title: Investigating glatiramer acetate for relapsing-remitting multiple sclerosis at the double dose--is more better?
authors.affiliation: Johns Hopkins Multiple Sclerosis Center, Baltimore, MD, USA. pcalabr1@jhmi.edu
authors.forename: Peter A
authors.initials: PA
authors.lastname: Calabresi